Cardiovascular efficacy and safety of antidiabetic agents: A network meta‐analysis of randomized controlled trials

M Sohn, JP Frias, S Lim - Diabetes, Obesity and Metabolism, 2023 - Wiley Online Library
Aim An important characteristic of glucose‐lowering therapies (GLTs) is their ability to
prevent cardiovascular complications. We aimed to investigate the cardiorenal efficacy and …
被引用次数：8 相关文章

Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials

M Sohn, JP Frias, S Lim - Diabetes, obesity & metabolism, 2023 - pubmed.ncbi.nlm.nih.gov
Aim An important characteristic of glucose-lowering therapies (GLTs) is their ability to
prevent cardiovascular complications. We aimed to investigate the cardiorenal efficacy and …

Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials.

M Sohn, JP Frias, S Lim - Diabetes, Obesity & Metabolism, 2023 - europepmc.org
Aim An important characteristic of glucose-lowering therapies (GLTs) is their ability to
prevent cardiovascular complications. We aimed to investigate the cardiorenal efficacy and …

Cardiovascular efficacy and safety of antidiabetic agents: A network meta-analysis of randomized controlled trials

M Sohn, JP Frias, S Lim - Diabetes, Obesity and …, 2023 - snucm.elsevierpure.com
Aim: An important characteristic of glucose-lowering therapies (GLTs) is their ability to
prevent cardiovascular complications. We aimed to investigate the cardiorenal efficacy and …